The AAPS Journal

, Volume 19, Issue 3, pp 797–805 | Cite as

Phloretin Prevents High-Fat Diet-Induced Obesity and Improves Metabolic Homeostasis

Research Article

Abstract

Reactive oxygen species generated as a by-product in metabolism play a central role in the development of obesity and obesity-related metabolic complications. The objective of the current study is to explore the possibility to block obesity and improve metabolic homeostasis via phloretin, a natural antioxidant product from apple tree leaves and Manchurian apricot. Both preventive and therapeutic activities of phloretin were assessed using a high-fat diet-induced obesity mouse model. Phloretin was injected intraperitoneally twice weekly into regular and obese mice fed a high-fat diet. The effects of phloretin treatment on body weight and composition, fat content in the liver, glucose and lipid metabolism, and insulin resistance were monitored and compared to the control animals. Phloretin treatment significantly blocks high-fat diet-induced weight gain but did not induce weight loss in obese animals. Phloretin improved glucose homeostasis and insulin sensitivity and alleviated hepatic lipid accumulation. RT-PCR analysis showed that phloretin treatment suppresses expression of macrophage markers (F4/80 and Cd68) and pro-inflammatory genes (Mcp-1 and Ccr2) and enhances adiponectin gene expression in white adipose tissue. In addition, phloretin treatment elevated the expression of fatty acid oxidation genes such as carnitine palmitoyltransferase 1a and 1b (Cpt1a and Cpt1b) and reduced expression of monocyte chemoattractant protein-1 (Mcp-1), de novo lipogenesis transcriptional factor peroxisome proliferator-activated receptor-γ 2 (Pparγ2), and its target monoacylglycerol O-acyltransferase (Mgat-1) genes. These results provide direct evidence to support a possible use of phloretin for mitigation of obesity and maintenance of metabolic homeostasis.

KEY WORDS

antioxidant inflammation insulin resistance obesity phloretin 

References

  1. 1.
    Pi-Sunyer X. The medical risks of obesity. Postgrad Med. 2009;121:21–33.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Daniels SR. Complications of obesity in children and adolescents. Int J Obes (Lond). 2009;33 Suppl 1:S60–5.CrossRefGoogle Scholar
  3. 3.
    Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief. 2015:1–8.Google Scholar
  4. 4.
    Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep. 2005;5:70–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Sun S, Ji Y, Kersten S, Qi L. Mechanisms of inflammatory responses in obese adipose tissue. Annu Rev Nutr. 2012;32:261–86.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond). 2006;30:400–18.CrossRefGoogle Scholar
  7. 7.
    Matsuzawa-Nagata N, Takamura T, Ando H, Nakamura S, Kurita S, Misu H, et al. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism. 2008;57:1071–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Paglialunga S, Ludzki A, Root-McCaig J, Holloway GP. In adipose tissue, increased mitochondrial emission of reactive oxygen species is important for short-term high-fat diet-induced insulin resistance in mice. Diabetologia. 2015;58:1071–80.CrossRefPubMedGoogle Scholar
  9. 9.
    Cui R, Gao M, Qu S, Liu D. Overexpression of superoxide dismutase 3 gene blocks high-fat diet-induced obesity, fatty liver and insulin resistance. Gene Ther. 2014;21:840–8.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Cho SJ, Jung UJ, Choi MS. Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice. Br J Nutr. 2012;108:2166–75.CrossRefPubMedGoogle Scholar
  11. 11.
    Dong J, Zhang X, Zhang L, Bian HX, Xu N, Bao B, et al. Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: a mechanism including AMPKalpha1/SIRT1. J Lipid Res. 2014;55:363–74.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Dinh CH, Szabo A, Camer D, Yu Y, Wang H, Huang XF. Bardoxolone methyl prevents fat deposition and inflammation in the visceral fat of mice fed a high-fat diet. Chem Biol Interact. 2015;229:1–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Ma Y, Gao M, Liu D. Chlorogenic acid improves high fat diet-induced hepatic steatosis and insulin resistance in mice. Pharm Res. 2015;32:1200–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol. 2003;91(suppl):7A–11A.Google Scholar
  15. 15.
    Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 2010;49:1603–16.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009;7:65–74.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Fearon IM, Faux SP. Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. J Mol Cell Cardiol. 2009;47:372–81.CrossRefPubMedGoogle Scholar
  18. 18.
    Romano AD, Serviddio G, de Matthaeis A, Bellanti F, Vendemiale G. Oxidative stress and aging. J Nephrol. 2010;23(Suppl 15):S29–36.Google Scholar
  19. 19.
    Basu A, Sanchez K, Leyva MJ, Wu M, Betts NM, Aston CE, et al. Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J Am Coll Nutr. 2010;29:31–40.CrossRefPubMedGoogle Scholar
  20. 20.
    Graffouillere L, Deschasaux M, Mariotti F, Neufcourt L, Shivappa N, Hebert JR. Prospective association between the Dietary Inflammatory Index and mortality: modulation by antioxidant supplementation in the SU.VI.MAX randomized controlled trial. Am J Clin Nutr. 2016;103:878–85.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Suzuki-Sugihara N, Kishimoto Y, Saita E, Taguchi C, Kobayashi M, Ichitani M, et al. Green tea catechins prevent low-density lipoprotein oxidation via their accumulation in low-density lipoprotein particles in humans. Nutr Res. 2016;36:16–23.CrossRefPubMedGoogle Scholar
  22. 22.
    de Gaetano G, Collaborative Group of the Primary Prevention P. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet. 2001;357:89–95.CrossRefPubMedGoogle Scholar
  23. 23.
    Steinhubl SR. Why have antioxidants failed in clinical trials? Am J Cardiol. 2008;101(suppl):14D–19D.Google Scholar
  24. 24.
    Alves NE, Enes BN, Martino HS, Alfenas Rde C, Ribeiro SM. Meal replacement based on Human Ration modulates metabolic risk factors during body weight loss: a randomized controlled trial. Eur J Nutr. 2014;53:939–50.CrossRefPubMedGoogle Scholar
  25. 25.
    Mielgo-Ayuso J, Barrenechea L, Alcorta P, Larrarte E, Margareto J, Labayen I. Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial. Br J Nutr. 2014;111:1263–71.CrossRefPubMedGoogle Scholar
  26. 26.
    Rezk BM, Haenen GR, van der Vijgh WJ, Bast A. The antioxidant activity of phloretin: the disclosure of a new antioxidant pharmacophore in flavonoids. Biochem Biophys Res Commun. 2002;295:9–13.CrossRefPubMedGoogle Scholar
  27. 27.
    Yang YC, Lii CK, Lin AH, Yeh YW, Yao HT, Li CC, et al. Induction of glutathione synthesis and heme oxygenase 1 by the flavonoids butein and phloretin is mediated through the ERK/Nrf2 pathway and protects against oxidative stress. Free Radic Biol Med. 2011;51:2073–81.CrossRefPubMedGoogle Scholar
  28. 28.
    Ullen A, Fauler G, Bernhart E, Nusshold C, Reicher H, Leis HJ, et al. Phloretin ameliorates 2-chlorohexadecanal-mediated brain microvascular endothelial cell dysfunction in vitro. Free Radic Biol Med. 2012;53:1770–81.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Vineetha VP, Soumya RS, Raghu KG. Phloretin ameliorates arsenic trioxide induced mitochondrial dysfunction in H9c2 cardiomyoblasts mediated via alterations in membrane permeability and ETC complexes. Eur J Pharmacol. 2015;754:162–72.CrossRefPubMedGoogle Scholar
  30. 30.
    de Oliveira MR. Phloretin-induced cytoprotective effects on mammalian cells: a mechanistic view and future directions. Biofactors. 2016;42:13–40.PubMedGoogle Scholar
  31. 31.
    Najafian M, Jahromi MZ, Nowroznejhad MJ, Khajeaian P, Kargar MM, Sadeghi M, et al. Phloridzin reduces blood glucose levels and improves lipids metabolism in streptozotocin-induced diabetic rats. Mol Biol Rep. 2012;39:5299–306.CrossRefPubMedGoogle Scholar
  32. 32.
    Hassan M, El Yazidi C, Malezet-Desmoulins C, Amiot MJ, Margotat A. Gene expression profiling of 3T3-L1 adipocytes exposed to phloretin. J Nutr Biochem. 2010;21:645–52.CrossRefPubMedGoogle Scholar
  33. 33.
    Shu G, Lu NS, Zhu XT, Xu Y, Du MQ, Xie QP, et al. Phloretin promotes adipocyte differentiation in vitro and improves glucose homeostasis in vivo. J Nutr Biochem. 2014;25:1296–308.CrossRefPubMedGoogle Scholar
  34. 34.
    Lin CC, Chu CL, Ng CS, Lin CY, Chen DY, Pan IH, et al. Immunomodulation of phloretin by impairing dendritic cell activation and function. Food Funct. 2014;5:997–1006.CrossRefPubMedGoogle Scholar
  35. 35.
    Chang WT, Huang WC, Liou CJ. Evaluation of the anti-inflammatory effects of phloretin and phlorizin in lipopolysaccharide-stimulated mouse macrophages. Food Chem. 2012;134:972–9.CrossRefPubMedGoogle Scholar
  36. 36.
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796–808.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Bu L, Gao M, Qu S, Liu D. Intraperitoneal injection of clodronate liposomes eliminates visceral adipose macrophages and blocks high-fat diet-induced weight gain and development of insulin resistance. AAPS J. 2013;15:1001–11.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Anstee QM, Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol. 2006;87:1–16.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Winzell MS, Ahren B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes. 2004;53 Suppl 3:S215–9.CrossRefPubMedGoogle Scholar
  41. 41.
    Huang WC, Wu SJ, Tu RS, Lai YR, Liou CJ. Phloretin inhibits interleukin-1beta-induced COX-2 and ICAM-1 expression through inhibition of MAPK, Akt, and NF-kappaB signaling in human lung epithelial cells. Food Funct. 2015.Google Scholar
  42. 42.
    Huang WC, Chang WT, Wu SJ, Xu PY, Ting NC, Liou CJ. Phloretin and phlorizin promote lipolysis and inhibit inflammation in mouse 3T3-L1 cells and in macrophage-adipocyte co-cultures. Mol Nutr Food Res. 2013;57:1803–13.PubMedGoogle Scholar
  43. 43.
    Kawano Y, Cohen DE. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J Gastroenterol. 2013;48:434–41.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Zuo AR, Yu YY, Shu QL, Zheng LX, Wang XM, Peng SH, et al. Hepatoprotective effects and antioxidant, antityrosinase activities of phloretin and phloretin isonicotinyl hydrazone. J Chin Med Assoc. 2014;77:290–301.CrossRefPubMedGoogle Scholar
  45. 45.
    Schulze C, Bangert A, Kottra G, Geillinger KE, Schwanck B, Vollert H, et al. Inhibition of the intestinal sodium-coupled glucose transporter 1 (SGLT1) by extracts and polyphenols from apple reduces postprandial blood glucose levels in mice and humans. Mol Nutr Food Res. 2014;58:1795–808.CrossRefPubMedGoogle Scholar
  46. 46.
    Skopec MM, Green AK, Karasov WH. Flavonoids have differential effects on glucose absorption in rats (Rattus norvegicus) and American robins (Turdis migratorius). J Chem Ecol. 2010;36:236–43.CrossRefPubMedGoogle Scholar
  47. 47.
    Ehrenkranz JR, Lewis NG, Kahn CR, Roth J. Phlorizin: a review. Diabetes Metab Res Rev. 2005;21:31–8.CrossRefPubMedGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2017

Authors and Affiliations

  1. 1.Department of Pharmaceutical and Biomedical Sciences, College of PharmacyUniversity of GeorgiaAthensUSA

Personalised recommendations